
doi: 10.2217/pgs.11.100
pmid: 22008043
1367 ISSN 1462-2416 10.2217/PGS.11.100 © 2011 Future Medicine Ltd Pharmacogenomics (2011) 12(10), 1367–1370 “Although PGx testing may very well one day fulfill its promise of preventing serious consequences of adverse drug reactions as well as avoiding the costs of giving certain drugs to patients who are probably nonresponders, we caution against the premature translation of such tests directly to the public.”
Pharmacogenetics, Community Participation, Humans, Genetic Testing, Delivery of Health Care
Pharmacogenetics, Community Participation, Humans, Genetic Testing, Delivery of Health Care
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
